SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-22-003374
Filing Date
2022-09-09
Accepted
2022-09-09 16:09:15
Documents
1
Period of Report
2022-09-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4323
  Complete submission text file 0001178913-22-003374.txt   5738
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address KIRYAT HADASSAH MINRAV BUILDING, FIFTH FLOOR JERUSALEM L3 9112002
Business Address
Santora Arthur C II (Reporting) CIK: 0001904746 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38556 | Film No.: 221236302